Bennett Jm

Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.

Robert G. Hahn, Matthias R. Bauer, J Wolter et al. · Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) · 1979 · 28 citations

Megestrol Acetate, Urology, Oncology +13

High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group.

Hines Jd, Mazza Jj, Oken Mm et al. · PubMed · 1985 · 20 citations

Hematological Malignancy, Health Sciences, Medicine +11

Phase II study of adriamycin and bleomycin in patients with multiple myeloma.

Bennett Jm, R. Silber, Ediz Z. Ezdinli et al. · PubMed · 1978 · 15 citations

Twenty-seven Patients, Hematological Malignancy, Oncology +15

Phase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel.

Jennifer Horton, A Mittelman, Taylor Sg et al. · PubMed · 1975 · 14 citations

Large Bowel, Gastrointestinal Pharmacology, Gastroenterology +16

Classifications of acute myeloid leukemia.

J Goasguen, Bennett Jm · PubMed · 1990 · 11 citations